UB Paderborn / Katalog / Suche / in CDI

Pegylated interferon alfa-2a for polycythemia vera or essential thrombocythemia resistant or intolerant to hydroxyurea

Blood, 2019-10, Vol.134 (18), p.1498-1509

2019

Volltextzugriff (PDF)

Conventional Cytogenetic Analysis and Array CGH + SNP Identify Essential Thrombocythemia and Prefibrotic Primary Myelofibrosis Patients Who Are at Risk for Disease Progression

International journal of molecular sciences, 2024-04, Vol.25 (7), p.4061

2024

Volltextzugriff (PDF)

Multiploid Inheritance of HIV-1 during Cell-to-Cell Infection

Journal of Virology, 2011-07, Vol.85 (14), p.7169-7176

2011

Volltextzugriff (PDF)

Oncogene-mediated alterations in chromatin conformation

Proceedings of the National Academy of Sciences - PNAS, 2012-06, Vol.109 (23), p.9083-9088

2012

Volltextzugriff (PDF)

Spleens of myelofibrosis patients contain malignant hematopoietic stem cells

The Journal of clinical investigation, 2012-11, Vol.122 (11), p.3888-3899

2012

Volltextzugriff (PDF)

Chromothripsis in lipoblastoma: second reported case with complex PLAG1 rearrangement

Molecular cytogenetics, 2023-11, Vol.16 (1), p.1-32, Article 32

2023

Volltextzugriff (PDF)

Characterization of disease-propagating stem cells responsible for myeloproliferative neoplasm-blast phase

JCI insight, 2022-04, Vol.7 (8)

2022

Volltextzugriff (PDF)

Frequency of heterozygous TET2 deletions in myeloproliferative neoplasms

Cancer management and research, 2010-09, Vol.2 (default), p.219-223

2010

Volltextzugriff (PDF)

Exon-Level Genomic Abnormalities Are Frequent in Cytogenetically Normal Patients with Philadelphia-Chromosome Negative Myeloproliferative Neoplasms (MPNs)

Blood, 2019-11, Vol.134 (Supplement_1), p.1687-1687

2019

Volltextzugriff (PDF)

A randomized phase 3 trial of interferon-α vs hydroxyurea in polycythemia vera and essential thrombocythemia

Blood, 2022-05, Vol.139 (19), p.2931-2941

2022

Volltextzugriff (PDF)

Host Nuclear Genome Copy Number Variations Identify High-Risk Anal Precancers in People Living With HIV

Journal of acquired immune deficiency syndromes (1999), 2024-06, Vol.96 (2), p.190

2024

Volltextzugriff (PDF)

Dual Driver Mutant BCR-ABL1-Negative Myeloid Neoplasms: Multicenter Clinicopathologic and Genomic Analysis

Blood, 2019-11, Vol.134 (Supplement_1), p.4173-4173

2019

Volltextzugriff (PDF)

Abstract 422: Placental Cdx2 Cells Regenerate Injured Myocardium

Circulation research, 2019-08, Vol.125 (Suppl_1)

2019

Volltextzugriff (PDF)

Multipotent fetal-derived Cdx2 cells from placenta regenerate the heart

Proceedings of the National Academy of Sciences - PNAS, 2019-06, Vol.116 (24), p.11786-11795

2019

Volltextzugriff (PDF)

BCR-ABL1 is a secondary event after JAK2V617F in patients with polycythemia vera who develop chronic myeloid leukemia

Blood, 2013-02, Vol.121 (7), p.1238-1239

2013

Volltextzugriff (PDF)

Significance of Abnormalities of PPM1D in Myeloproliferative Neoplasms

Blood, 2019-11, Vol.134 (Supplement_1), p.4207-4207

2019

Volltextzugriff (PDF)

Advanced forms of MPNs are accompanied by chromosomal abnormalities that lead to dysregulation of TP53

Blood advances, 2018-12, Vol.2 (24), p.3581-3589

2018

Volltextzugriff (PDF)

Combination treatment in vitro with Nutlin, a small-molecule antagonist of MDM2, and pegylated interferon-α 2a specifically targets JAK2V617F-positive polycythemia vera cells

Blood, 2012-10, Vol.120 (15), p.3098-3105

2012

Volltextzugriff (PDF)

JAK2 inhibitors do not affect stem cells present in the spleens of patients with myelofibrosis

Blood, 2014-11, Vol.124 (19), p.2987-2995

2014

Volltextzugriff (PDF)

Fetal Cells Traffic to Injured Maternal Myocardium and Undergo Cardiac Differentiation

Circulation research, 2012-01, Vol.110 (1), p.82-93

2012

Volltextzugriff (PDF)

Advanced Forms of the Myeloproliferative Neoplasms Are Associated with Chromosomal Abnormalities Involving 1q and 12q: Implicating MDM2 and MDM4 in Disease Progression

Blood, 2017-12, Vol.130, p.204-204

2017

Volltextzugriff (PDF)

Myeloproliferative Neoplasm (MPN) Blastic Transformation Occurs at the Level of Both Short and Long Term Hematopoietic Stem Cells

Blood, 2017-12, Vol.130, p.2943-2943

2017

Volltextzugriff (PDF)

Myeloproliferative Neoplasm (MPN) Blastic Transformation Occurs at the Level of Hematopoietic Stem Cells

Blood, 2018-11, Vol.132 (Supplement 1), p.101-101

2018

Volltextzugriff (PDF)

Abstract 198: Multipotent Placenta-derived Cdx2 Cells Possess in vitro and in vivo Cardiomyogenic Potential

Circulation research, 2017-07, Vol.121 (suppl_1)

2017

Volltextzugriff (PDF)

Abstract 5757: Study of human mammary tumor virus (HMTV) in human breast cancer by NanoString nCounter and FISH analysis

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.5757-5757

2017

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Pegylated interferon alfa-2a for polycythemia vera or essential thrombocythemia resistant or intolerant to hydroxyurea

Conventional Cytogenetic Analysis and Array CGH + SNP Identify Essential Thrombocythemia and Prefibrotic Primary Myelofibrosis Patients Who Are at Risk for Disease Progression

Multiploid Inheritance of HIV-1 during Cell-to-Cell Infection

Oncogene-mediated alterations in chromatin conformation

Spleens of myelofibrosis patients contain malignant hematopoietic stem cells

Chromothripsis in lipoblastoma: second reported case with complex PLAG1 rearrangement

Characterization of disease-propagating stem cells responsible for myeloproliferative neoplasm-blast phase

Frequency of heterozygous TET2 deletions in myeloproliferative neoplasms

Exon-Level Genomic Abnormalities Are Frequent in Cytogenetically Normal Patients with Philadelphia-Chromosome Negative Myeloproliferative Neoplasms (MPNs)

A randomized phase 3 trial of interferon-α vs hydroxyurea in polycythemia vera and essential thrombocythemia

Host Nuclear Genome Copy Number Variations Identify High-Risk Anal Precancers in People Living With HIV

Dual Driver Mutant BCR-ABL1-Negative Myeloid Neoplasms: Multicenter Clinicopathologic and Genomic Analysis

Abstract 422: Placental Cdx2 Cells Regenerate Injured Myocardium

Multipotent fetal-derived Cdx2 cells from placenta regenerate the heart

BCR-ABL1 is a secondary event after JAK2V617F in patients with polycythemia vera who develop chronic myeloid leukemia

Significance of Abnormalities of PPM1D in Myeloproliferative Neoplasms

Advanced forms of MPNs are accompanied by chromosomal abnormalities that lead to dysregulation of TP53

Combination treatment in vitro with Nutlin, a small-molecule antagonist of MDM2, and pegylated interferon-α 2a specifically targets JAK2V617F-positive polycythemia vera cells

JAK2 inhibitors do not affect stem cells present in the spleens of patients with myelofibrosis

Fetal Cells Traffic to Injured Maternal Myocardium and Undergo Cardiac Differentiation

Advanced Forms of the Myeloproliferative Neoplasms Are Associated with Chromosomal Abnormalities Involving 1q and 12q: Implicating MDM2 and MDM4 in Disease Progression

Myeloproliferative Neoplasm (MPN) Blastic Transformation Occurs at the Level of Both Short and Long Term Hematopoietic Stem Cells

Myeloproliferative Neoplasm (MPN) Blastic Transformation Occurs at the Level of Hematopoietic Stem Cells

Abstract 198: Multipotent Placenta-derived Cdx2 Cells Possess in vitro and in vivo Cardiomyogenic Potential

Abstract 5757: Study of human mammary tumor virus (HMTV) in human breast cancer by NanoString nCounter and FISH analysis

Suchergebnisse filtern